Stocks Health care RCEL
NASDAQ · Health careAVITA Medical, Inc. (RCEL)
AVITA Medical, Inc. brought in $75.6M of revenue over the twelve months to June 30, 2026, up 1.0% from a year earlier. It posted a net loss of $43.1M. In fiscal 2025 capital spending exceeded operating cash flow by $32.2M. At June 30, 2026 it held $9.1M in cash against $46.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
Watch RCEL in 60 secondsWhat AVITA Medical, Inc. does
AVITA Medical, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker RCEL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $71.6M | -$48.6M | -$1.74 | -$32.2M |
| 2024 | $64.3M | -$61.8M | -$2.39 | -$58.1M |
| 2023 | $50.1M | -$35.4M | -$1.40 | -$39.4M |
| 2022 | $34.4M | -$26.7M | $1.07 | -$19.5M |
| 2021 | $29.2M | -$26.6M | $1.17 | -$26.8M |
| 2020 | $14.3M | -$42M | $2.07 | -$23.3M |
Full financial statements: income, balance sheet and cash flow
Where RCEL ranks in Health care
Latest SEC filings
What AVITA Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 25, 2026
- August 11, 2026
- August 6, 2026Shareholder vote results 8-K/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 18% to $21.7M versus the same quarter last year; diluted EPS -$0.25 versus -$0.38.
- August 6, 2026
- June 8, 2026
- June 8, 2026
- June 4, 2026
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 4% to $19.3M versus the same quarter last year; diluted EPS -$0.35 versus -$0.53.
- May 14, 2026
Insider trades
What the people running AVITA Medical, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 12, 2026 | O'Toole David DCFO | Bought | 2,000 | $7.9K |
| June 12, 2026 | O'Toole David DCFO | Received as pay | 2,000 | $7.9K |
| June 9, 2026 | Woody Joseph FralinDirector | Bought | 5,200 | $20.8K |
| June 9, 2026 | Woody Joseph FralinDirector | Bought | 5,000 | $21K |
| June 9, 2026 | Woody Joseph FralinDirector | Bought | 5,000 | $20.9K |
| June 3, 2026 | Woody Joseph FralinDirector | Bought | 5,000 | $20.5K |
| June 3, 2026 | Woody Joseph FralinDirector | Bought | 5,000 | $20.4K |
| June 2, 2026 | Woody Joseph FralinDirector | Bought | 5,000 | $20.9K |
| June 2, 2026 | Woody Joseph FralinDirector | Bought | 5,000 | $21K |
| June 1, 2026 | Woody Joseph FralinDirector | Bought | 5,000 | $21.7K |
| June 1, 2026 | Woody Joseph FralinDirector | Bought | 5,000 | $21.3K |
| May 29, 2026 | Vance Cary GuyPresident and CEO, Director | Received as pay | 5,000 | $15.3K |
| May 29, 2026 | O'Toole David DCFO | Received as pay | 5,000 | $15.3K |
| May 20, 2026 | O'Toole David DCFO | Bought | 2,000 | $8.5K |
| May 19, 2026 | O'Toole David DCFO | Bought | 2,000 | $8.5K |
Who owns RCEL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
9 insiders reported holding 761,921 shares in total, about $8.9M at the last price.
| Holder | Shares |
|---|---|
| O'Toole David DCFO | 152,927 |
| McNamara RobertDirector | 108,985 |
| Woody Joseph FralinDirector | 107,961 |
| Kelsey NicoleChief Legal Officer | 98,390 |
| Reed Jan SternDirector | 73,225 |
| Crowe SuzanneDirector | 69,148 |
| Cook Jeremy CurnockDirector | 62,050 |
| Tarnoff Michael EDirector | 48,464 |
| Vance Cary GuyPresident and CEO, Director | 40,771 |
Questions about RCEL
What does AVITA Medical, Inc. do?
AVITA Medical, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker RCEL.
Is AVITA Medical, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $43.1M on revenue of $75.6M.
How much revenue does AVITA Medical, Inc. make?
Over the twelve months to June 30, 2026 AVITA Medical, Inc. reported revenue of $75.6M. That is 1.0% more than a year earlier.
When did AVITA Medical, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the employee stock plan registration from August 25, 2026.
Similar companies
Compare RCEL with
Follow RCEL
Get an email when AVITA Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow RCEL: get an email when it filesWhere the numbers come from
Financial figures are the values AVITA Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.